Dimo Dietrich

19PUBLICATIONS
71CO-AUTHORS
Cancer geneticsNatural language processingPredictive and prognostic markersHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 12, 2026
Constitutional BRCA1 Promoter Methylation in Patients With Ovarian Cancer: Results of the Observational AGO-TR1 Study.

|Feb 06, 2026
Comparative Performance of agentic AI and Physicians in Taking Clinical History across Leading Large Language Models (LLMs).

Sophie Steinbuch, Luka de Vos-Hillebrand, Connor O'Neill-Dee

|Apr 24, 2024
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz

|Oct 23, 2023
PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma.

Niklas Klümper, Lennert Wüst, Jonas Saal

|Apr 12, 2022
DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy.

Dennis Niebel, Anne Fröhlich, Romina Zarbl

|Dec 28, 2021
Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer.

Konstantin Weber-Lassalle, Corinna Ernst, Alexander Reuss

Pageof 4

Frequent Collaborators

3 joint publications

Friedrich Bootz

2 joint publications

Jan Hauke

2 joint publications

Florian Heitz

2 joint publications

Alexander Burges